Schroders Capital Global Innovation Trust announced an investment of $1.6m (£1.3m) in Neurona Therapeutics, a prominent US-based clinical-stage cell therapy company, on Friday.
Schroder British Opportunities Trust PLC says investee EasyPark Group intends to acquire Flowbird Group, a Paris-based payment and ticketing systems company. Does not disclose terms of the deal,.
IN BRIEF: Schroder investee to buy Flowbird for undisclosed amount lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.